BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 29255075)

  • 1. Cutting Edge: Allograft Rejection Is Associated with Weak T Cell Responses to Many Different Graft Leukocyte-Derived Peptides.
    Burrack AL; Malhotra D; Dileepan T; Osum KC; Swanson LA; Fife BT; Jenkins MK
    J Immunol; 2018 Jan; 200(2):477-482. PubMed ID: 29255075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinogen-treated skin allografts rejected by T lymphocytes specific for class I but not class II MHC antigens.
    Halliday GM; Odling KA; Muller HK
    Cell Immunol; 1993 Oct; 151(2):291-9. PubMed ID: 8402936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited T cell response to donor MHC peptides during allograft rejection. Implications for selective immune therapy in transplantation.
    Benichou G; Fedoseyeva E; Lehmann PV; Olson CA; Geysen HM; McMillan M; Sercarz EE
    J Immunol; 1994 Aug; 153(3):938-45. PubMed ID: 7517977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histoincompatibility-associated differences in the phenotypes of murine cardiac allograft infiltrating T cells.
    Carlquist JF; Shelby J; Hammond EH; Greenwood JH; Anderson JL
    Immunology; 1994 May; 82(1):149-53. PubMed ID: 7913913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
    Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV
    Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contributions of direct and indirect T cell alloreactivity during allograft rejection in mice.
    Benichou G; Valujskikh A; Heeger PS
    J Immunol; 1999 Jan; 162(1):352-8. PubMed ID: 9886406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for involvement of dual-function T cells in rejection of MHC class I disparate skin grafts. Assessment of MHC class I alloantigens as in vivo helper determinants.
    Rosenberg AS; Mizuochi T; Singer A
    J Exp Med; 1988 Jul; 168(1):33-45. PubMed ID: 2456372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection.
    Benichou G; Takizawa PA; Olson CA; McMillan M; Sercarz EE
    J Exp Med; 1992 Jan; 175(1):305-8. PubMed ID: 1730925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory functions of self-restricted MHC class II allopeptide-specific Th2 clones in vivo.
    Waaga AM; Gasser M; Kist-van Holthe JE; Najafian N; Müller A; Vella JP; Womer KL; Chandraker A; Khoury SJ; Sayegh MH
    J Clin Invest; 2001 Apr; 107(7):909-16. PubMed ID: 11285310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of immunodominant donor MHC peptides following rejection and donor strain transfusion-induced tolerance of heart allografts in adult rats.
    van Denderen B; Pêche H; Gagne K; Usal C; Cuturi MC; Soulillou JP
    Eur J Immunol; 2001 May; 31(5):1333-9. PubMed ID: 11465090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered selection of CD4+ T cells by class II MHC bound with dominant and low abundance self-peptides.
    Gaszewska-Mastalarz A; Muranski P; Chmielowski B; Kraj P; Ignatowicz L
    J Immunol; 2000 Dec; 165(11):6099-106. PubMed ID: 11086042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resident memory T cells form during persistent antigen exposure leading to allograft rejection.
    Abou-Daya KI; Tieu R; Zhao D; Rammal R; Sacirbegovic F; Williams AL; Shlomchik WD; Oberbarnscheidt MH; Lakkis FG
    Sci Immunol; 2021 Mar; 6(57):. PubMed ID: 33741656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism.
    Lee I; Wang L; Wells AD; Ye Q; Han R; Dorf ME; Kuziel WA; Rollins BJ; Chen L; Hancock WW
    J Immunol; 2003 Dec; 171(12):6929-35. PubMed ID: 14662900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of CD4+ and CD8+ T cells in allorecognition: lessons from corneal transplantation.
    Boisgérault F; Liu Y; Anosova N; Ehrlich E; Dana MR; Benichou G
    J Immunol; 2001 Aug; 167(4):1891-9. PubMed ID: 11489968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts.
    Qian S; Fu F; Li Y; Lu L; Rao AS; Starzl TE; Thomson AW; Fung JJ
    Immunology; 1996 May; 88(1):124-9. PubMed ID: 8707337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of parathyroid graft rejection suggests alloantigen-specific production of nitric oxide by iNOS-positive intragraft macrophages.
    Matuschek A; Ulbrich M; Timm S; Schneider M; Thomas Germer C; Ulrichs K; Otto C
    Transpl Immunol; 2009 Sep; 21(4):183-91. PubMed ID: 19409993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions.
    Bishop DK; Chan Wood S; Eichwald EJ; Orosz CG
    J Immunol; 2001 Mar; 166(5):3248-55. PubMed ID: 11207279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute rejection in the absence of cognate recognition of allograft by T cells.
    Braun MY; Grandjean I; Feunou P; Duban L; Kiss R; Goldman M; Lantz O
    J Immunol; 2001 Apr; 166(8):4879-83. PubMed ID: 11290764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recipient-matching of Passenger Leukocytes Prolongs Survival of Donor Lung Allografts in Miniature Swine.
    Madariaga ML; Michel SG; La Muraglia GM; Sihag S; Leonard DA; Farkash EA; Colvin RB; Cetrulo CL; Huang CA; Sachs DH; Madsen JC; Allan JS
    Transplantation; 2015 Jul; 99(7):1372-8. PubMed ID: 25757217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-L1/PD-1 signal deficiency promotes allogeneic immune responses and accelerates heart allograft rejection.
    Wang W; Carper K; Malone F; Latchman Y; Perkins J; Fu Y; Reyes J; Li W
    Transplantation; 2008 Sep; 86(6):836-44. PubMed ID: 18813109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.